Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are over 18 years old and have been diagnosed with, or are strongly suspected to have, a lung scarring/stiffening condition called interstitial lung disease (ILD), or have a related connective tissue disease diagnosed at least 5 years ago
- You are willing and able to sign a consent form allowing your data to be collected for this study
Who may not be able to join:
- You currently have an active infection
- You have been diagnosed with coronary artery disease (a condition affecting the blood vessels of the heart)
- You have previously had a procedure to open or bypass blocked heart arteries (such as a stent or bypass surgery)
- You have a known heart muscle disease (cardiomyopathy)
- You have a history of heart failure
- You have any cardiac devices, such as an artificial heart valve, pacemaker, defibrillator, or heart pump
- You have had cancer in the past or currently have cancer
- You are pregnant or breastfeeding
- You have an allergy to iodine-based contrast dye (a substance sometimes used in scans)
- You experience claustrophobia (fear of enclosed spaces)
- Your kidneys are not working well enough (confirm with trial site for exact kidney function measurement)
- You are unable to lie flat or hold your breath during a scan
- You are unwilling or unable to sign the informed consent form
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0226436106
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
a low dose image protocol able to characterize ILD related lung parenchyma alteration and new quantitative imaging biomarkers of lung disease severity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.